Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (6)

2023

  1. Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

2022

  1. Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

2020

  1. Cutaneous Wound Healing in Diabetic Mice Is Improved by Topical Mineralocorticoid Receptor Blockade

    Journal of Investigative Dermatology, Vol. 140, Núm. 1, pp. 223-234.e7

2019

  1. MR (Mineralocorticoid Receptor) Induces Adipose Tissue Senescence and Mitochondrial Dysfunction Leading to Vascular Dysfunction in Obesity

    Hypertension, Vol. 73, Núm. 2, pp. 458-468

  2. Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Mitochondrial oxidative stress in obesity: Role of the mineralocorticoid receptor

    Journal of Endocrinology, Vol. 238, Núm. 3, pp. R143-R159